Business
- Supplements in your stocking: Why wellness gifts are gaining steam for the holidays and beyond - Retailers are blurring the lines between beauty and wellness as customers look for holiday gifts and focus on self-care.
- Disney's 'Avatar: Fire and Ash' disappoints with weak $88 million domestic opening - Disney's "Avatar: Fire and Ash" tallied just $88 million during its domestic debut, well shy of the $110 million to $125 million range analysts had expected.
- AI was behind over 50,000 layoffs in 2025 — here are the top firms to cite it for job cuts - Some of the world's biggest tech companies cited AI as part of their layoff and restructuring strategy in 2025.
- How Build-A-Bear went from a penny stock to a retail winner - Build-A-Bear Workshop's business plummeted during the pandemic, but under CEO Sharon Price John, the company has undergone a significant turnaround.
- Nine of the largest pharma companies ink deals with Trump to lower drug prices - President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than overseas.
- UnitedHealth Group commits to improvements after independent audit, patient backlash - The company said it has adopted 23 ongoing "action plans" to track and implement recommended improvements, all of which will be completed by the end of March.
- Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple - Dealmakers expected a flood of M&A to take place in 2025 following the election of President Trump. The number of transactions didn't live up to the hype.
- This is how exposed European Big Pharma is to the U.S. - U.S. pricing has been the bigegts issue of the year for drugmakers heavily exposed to the U.S. market.
- Nike tops earnings estimates as rising North America sales help to offset China weakness - Nike posted fiscal second-quarter earnings and revenue that topped Wall Street's expectations as CEO Elliott Hill tries to turn around the company.
- Trump signs executive order reclassifying cannabis, opening door to broader weed access - President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.